US · NAKA
Nakamoto Inc.
- Sector
- Healthcare · Medical - Equipment & Services
- Headquarters
- Salt Lake City, UT 84117
- Website
- nakamoto.com
Price · as of 2024-12-31
$0.20
Market cap 92.19M
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $84.68 | +42,581.45% |
| Intrinsic Value(DCF) | $0.66 | +232.66% |
| Graham-Dodd Method(GD) | — | — |
| Graham Formula(GF) | $12.39 | +6,143.45% |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2010 | |||||
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | |||||
| 2020 | |||||
| 2021 | |||||
| 2022 | $0.00 | $0.00 | |||
| 2023 | $0.00 | $0.00 | |||
| 2024 | $1.65 | $84.68 | $0.00 | $0.00 | $12.39 |
AI valuation
Our deep-learning model estimates Nakamoto Inc.'s (NAKA) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $84.68
- Current price
- $0.20
- AI upside
- +42,581.45%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$0.66
+232.66% upside
Graham-Dodd
—
— upside
Graham Formula
$12.39
+6,143.45% upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| NAKA | Nakamoto Inc. | $0.20 | 92.19M | +42,581% | +233% | — | +6,143% | -2.46 | 3.46 | 3.27 | -2.47 | -1.66 | 4.08 | 96.96% | -123.05% | -133.01% | -294.13% | -619.29% | -151.45% | 0.31 | -8.51 | 4.13 | 3.81 | 0.50 | 14815.00% | -2783.00% | 64918.00% | -39.07% | -5.07 | -643.12% | 0.00% | 0.00% | 18.24% | -2.21 | -2.13 | 2.72 | 0.21 |
| AGL | Agilon Health, Inc. | $0.59 | 244.31M | +3,319% | +1,042% | — | — | -0.65 | 2.01 | 0.04 | 0.03 | -1.17 | 4.18 | -3.18% | -7.10% | -6.83% | -130.95% | 2821.09% | -26.04% | 0.15 | -63.41 | 1.02 | 0.89 | 0.42 | 5556.00% | -211.00% | 6755.00% | -46.67% | -0.10 | 797.30% | 0.00% | 0.00% | 2.97% | 0.03 | 0.09 | 0.00 | 1.55 |
| AMRN | Amarin Corporation plc | $13.80 | 285.42M | +2,553% | -43% | -73% | +374% | -2.65 | 0.45 | 0.95 | 0.93 | -7.95 | 0.46 | 35.60% | -40.15% | -35.95% | -15.83% | -41.74% | -10.83% | 0.02 | -13113.86 | 3.31 | 2.31 | 1.53 | 3333.00% | -2551.00% | -55089.00% | -14.25% | -0.17 | -14.11% | 0.00% | 0.00% | 0.00% | 0.75 | 2.21 | -0.30 | -2.13 |
| CLLS | Cellectis S.A. | $3.88 | 389.18M | +21,055% | +605% | — | — | -3.10 | 0.87 | 2.74 | 5.83 | — | 0.87 | 77.88% | -143.48% | -88.57% | -34.02% | 165.71% | -10.22% | 0.70 | -7.99 | 1.73 | 1.70 | 5.47 | -7684.00% | 539748.00% | -17562.00% | 17.18% | 0.13 | -54.33% | 0.00% | 0.00% | 0.12% | 0.93 | -2.83 | -1.33 | -0.96 |
| DBVT | DBV Technologies S.A. | $20.99 | 502.12M | -17% | — | — | — | -0.71 | 2.93 | — | -0.50 | -1.28 | 2.94 | 0.00% | — | — | -135.96% | -2872.45% | -91.63% | 0.28 | — | 1.43 | 1.38 | 0.22 | 5526.00% | -10000.00% | 3297.00% | -132.98% | -3.36 | -2637.08% | 0.00% | 0.00% | 0.06% | -0.46 | -0.52 | — | -10.66 |
| DCTH | Delcath Systems, Inc. | $8.90 | 308.83M | +1,206% | — | — | — | 118.48 | 2.88 | — | 59.54 | — | 2.88 | 0.00% | — | — | 3.00% | 2.70% | 2.70% | 0.01 | — | 10.92 | 9.39 | -11.02 | -10756.00% | -10000.00% | -20899.00% | 6.56% | 2.06 | 111.33% | 0.00% | 0.00% | 3.63% | 348.16 | 10.96 | — | 10.54 |
| DH | Definitive Healthcare Cor… | $1.28 | 132.23M | +1,820% | +27% | — | — | -0.61 | 0.32 | 0.50 | 0.32 | — | -1.85 | 75.88% | -8.52% | -57.52% | -48.41% | -6.39% | -21.84% | 0.02 | -1.82 | 1.64 | 1.49 | 0.96 | -6328.00% | -424.00% | -1918.00% | 30.48% | 0.34 | 12.09% | 0.00% | 0.00% | 290.32% | 2.50 | -1.39 | -0.21 | 0.60 |
| LRMR | Larimar Therapeutics, Inc… | $5.31 | 454.48M | — | — | — | — | -2.30 | 1.08 | — | -0.08 | -4.03 | 1.08 | 0.00% | — | — | -63.58% | 3005.12% | -54.43% | 0.03 | — | 8.02 | 7.58 | 0.31 | 5714.00% | — | 11198.00% | -38.40% | -2.91 | 2356.59% | 0.00% | 0.00% | 3.72% | -0.08 | -0.10 | — | 1.56 |
| LYEL | Lyell Immunopharma, Inc. | $24.00 | 509.85M | -75% | -75% | — | +4,553% | -0.57 | 0.51 | 3184.91 | 0.58 | -1.41 | 0.51 | 100.00% | -588122.95% | -562285.25% | -66.10% | -295.08% | -55.28% | 0.15 | — | 7.06 | 6.89 | 0.23 | 4014.00% | -5308.00% | -212.00% | -83.83% | -3.02 | -133.95% | 0.00% | 0.00% | 0.00% | 0.33 | 0.72 | -1922.61 | -4.37 |
| SLP | Simulations Plus, Inc. | $12.23 | 246.39M | +509% | -44% | — | — | -5.32 | 2.76 | 4.35 | 21.26 | — | 6.64 | 58.38% | -89.33% | -81.74% | -42.13% | -51.50% | -38.12% | 0.00 | — | 7.67 | 6.98 | -2.06 | -75714.00% | 1309.00% | 3653.00% | 5.06% | 2.70 | 13.59% | 0.00% | 0.00% | 6.08% | -4.42 | 17.95 | 3.95 | 27.83 |
| SOPH | SOPHiA GENETICS S.A. | $4.50 | 305.31M | +461% | -71% | — | — | -3.48 | 2.21 | 3.27 | -3.21 | — | 3.16 | 67.42% | -102.14% | -95.89% | -49.42% | -143.02% | -33.90% | 0.31 | -34.80 | 3.71 | 3.32 | 0.99 | -2213.00% | 449.00% | -1177.00% | -23.93% | -1.60 | -109.57% | 0.00% | 0.00% | 0.00% | -2.45 | -3.19 | 2.50 | -2.23 |
About Nakamoto Inc.
Nakamoto Inc. develops and invests in a global portfolio of Bitcoin-native companies. The company provides commercial and financial infrastructure for the capital markets. The company was formerly known as Kindly MD, Inc. and change its name to Nakamoto Inc. in January 2026. The company was incorporated in 2019 and is based in Nashville, Tennessee.
- CEO
- David Forrest Bailey
- Employees
- 23
- Beta
- -0.90
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($0.66 ÷ $0.20) − 1 = +232.66% (DCF, example).